<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; General Health</title>
	<atom:link href="http://www.canadiannetmall.com/blog/category/general-health/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Donepezil and Activities of Daily Living</title>
		<link>http://www.canadiannetmall.com/blog/donepezil-and-activities-of-daily-living/</link>
		<comments>http://www.canadiannetmall.com/blog/donepezil-and-activities-of-daily-living/#comments</comments>
		<pubDate>Mon, 04 Apr 2011 07:05:59 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Daily Living]]></category>
		<category><![CDATA[Donepezil]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4537</guid>
		<description><![CDATA[Even at the more advanced stages of Alzheimer&#8217;s disease (AD), donepezil (Aricept medication, Eisai) can enhance quality of life for both patients and caregivers, according to a study of patients with moderate-to-severe AD. Treatment with donepezil (5 mg/day for four weeks and 10 mg/day, subject to the clinician&#8217;s judgment, thereafter) significantly slowed a decline in [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/donepezil-and-activities-of-daily-living/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Levodopa Combination for Parkinson&#8217;s Disease</title>
		<link>http://www.canadiannetmall.com/blog/levodopa-combination-for-parkinsons-disease/</link>
		<comments>http://www.canadiannetmall.com/blog/levodopa-combination-for-parkinsons-disease/#comments</comments>
		<pubDate>Fri, 01 Apr 2011 07:05:55 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Levodopa Combination]]></category>
		<category><![CDATA[Parkinson's Disease]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4543</guid>
		<description><![CDATA[The U.S. Food and Drug Administration (FDA) has approved Stalevo™ (carbidopa, levodopa, and entacapone) tablets for the treatment of patients with idio-pathic Parkinson&#8217;s disease who experience diminished benefits as the effects of levodopa wear off. Novartis plans to market the drug, and Orion Pharma will manufacture it in the U.S. Parkinson&#8217;s disease affects more than [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/levodopa-combination-for-parkinsons-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Generic Capsules Approved for Severe Acne</title>
		<link>http://www.canadiannetmall.com/blog/generic-capsules-approved-for-severe-acne/</link>
		<comments>http://www.canadiannetmall.com/blog/generic-capsules-approved-for-severe-acne/#comments</comments>
		<pubDate>Sun, 20 Mar 2011 07:05:38 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Generic Capsules]]></category>
		<category><![CDATA[Severe Acne]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4567</guid>
		<description><![CDATA[Barr Laboratories has announced that the FDA has approved its application to manufacture and market a generic version of Accutane tablet (canadian isotretinoin, Roche) capsules, in strengths of 10, 20, and 40 mg. The company plans to market Clar-avisTM as a generic brand and to launch it in May 2003. ClaravisTM is indicated for the [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/generic-capsules-approved-for-severe-acne/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abacavir and Hypersensitivity</title>
		<link>http://www.canadiannetmall.com/blog/abacavir-and-hypersensitivity/</link>
		<comments>http://www.canadiannetmall.com/blog/abacavir-and-hypersensitivity/#comments</comments>
		<pubDate>Fri, 18 Feb 2011 07:15:20 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Abacavir]]></category>
		<category><![CDATA[Hypersensitivity]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4418</guid>
		<description><![CDATA[Abacavir sulfate (Ziagen®, GlaxoSmithKline), a nucleoside reverse tran-scriptase inhibitor (NRTI) used to treat human immunodeficiency virus 1 (HIV-1) infection in combination with other antiretroviral agents, is well tolerated except for the development of hyper-sensitivity reactions. These effects are the main reason for stopping the drug within the first months of therapy. Abacavir can be associated [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/abacavir-and-hypersensitivity/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Complexities of Simplifying HAART</title>
		<link>http://www.canadiannetmall.com/blog/the-complexities-of-simplifying-haart/</link>
		<comments>http://www.canadiannetmall.com/blog/the-complexities-of-simplifying-haart/#comments</comments>
		<pubDate>Sun, 13 Feb 2011 07:15:14 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Complexities]]></category>
		<category><![CDATA[Simplifying HAART]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4428</guid>
		<description><![CDATA[For clinicians who would like to simplify their patients&#8217; HAART regimens (highly active retroviral therapies) by replacing the protease inhibitor (PI), nevirapine (Viramune drug, Boehringer Ingelheim) or efavirenz (Sustiva drug, Bristol-Myers Squibb Oncology) might be a better choice than abacavir (Ziagen®, Glaxo-SmithKline), according to the Nevira-pine/Efavirenz/Abacavir Study Team. The researchers randomly assigned 460 adults who [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/the-complexities-of-simplifying-haart/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rivastigmine May Help Parkinson&#8217;s Disease Patients with Dementia</title>
		<link>http://www.canadiannetmall.com/blog/rivastigmine-may-help-parkinsons-disease-patients-with-dementia/</link>
		<comments>http://www.canadiannetmall.com/blog/rivastigmine-may-help-parkinsons-disease-patients-with-dementia/#comments</comments>
		<pubDate>Thu, 11 Nov 2010 20:15:58 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Dementia]]></category>
		<category><![CDATA[Parkinson's Disease]]></category>
		<category><![CDATA[Rivastigmine]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3996</guid>
		<description><![CDATA[A medication used to treat Alzheimer&#8217;s disease (AD), rivastigmine tartrate (Exelon canadian, Novartis), provides important benefits in symptoms of dementia in patients with Parkinson&#8217;s disease (PD). Patients who took rivastigmine functioned better overall and showed improved cognition and behavioral symptoms, compared with patients taking placebo. A chronic and progressive disease of the nervous system, PD [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/rivastigmine-may-help-parkinsons-disease-patients-with-dementia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Teratogenic Drugs: Reassessing the Risks</title>
		<link>http://www.canadiannetmall.com/blog/teratogenic-drugs-reassessing-the-risks/</link>
		<comments>http://www.canadiannetmall.com/blog/teratogenic-drugs-reassessing-the-risks/#comments</comments>
		<pubDate>Sun, 26 Sep 2010 08:49:47 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[General Health]]></category>
		<category><![CDATA[Teratogenic Drugs]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3759</guid>
		<description><![CDATA[Each year, millions of women of child-bearing age are prescribed drugs that have the potential to cause birth defects, according to a study from the University of Pittsburgh and the University of California, San Francisco. During an estimated 11 million annual office visits, 11.7 million class D or class X medications were documented. Class D [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/teratogenic-drugs-reassessing-the-risks/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

